About Dr. Rachel M. Barbee
Dr. Rachel Barbee (née Bartlett) is an ABR certified Nuclear Medical Physicist and Associate Professor in the Department of Imaging Physics at the University of Texas MD Anderson Cancer Center. She obtained her PhD in Medical Physics from the University of Wisconsin – Madison studying environmental neurotoxins in utero using PET imaging of novel radiotracers. After defending her thesis, she joined the Nuclear Medicine group at Memorial Sloan Kettering in New York City as a post-doctoral fellow. Her work at MSKCC shifted her research focus from neurological conditions to the study of hypoxia in cancer. In 2012 she joined NYU Langone Health as the clinical nuclear medicine physicist and an Assistant Professor in the Department of Radiology, where in addition to providing clinical support she provided administrative support sitting on the IRB, IACUC, RDRC, and radiation safety committee in addition to educational roles for medical residents and clinical staff. In 2022 Dr. Barbee moved to Houston to join the Nuclear Medicine Physics group in the Department of Imaging Physics at MD Anderson Cancer Center where she provides daily support of clinical diagnostic and therapeutic nuclear medicine procedures.
Dr Barbee’s interest focuses on the practical implementation of radionuclide therapy, particularly theranostics, and personalized dosimetry. She is passionate about educating and improving the nuclear medicine community as an active member of the SNMMI MIRD (medical internal radiation dosimetry) committee and quality standards as a member of the nuclear medicine subcommittee of the ACR. In addition to the training of medical physicists and radiology residents, Dr. Barbee supports the education and certification of fellows serving on multiple committees of the ABR.
Associate Professor, Department of Imaging Physics, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
|2009||University of Wisconsin, Madison, WI, USA, PHD, Medical Physics|
|2004||University of Wisconsin, Madison, WI, USA, MS, Medical Physics|
|2002||Oregon State University, Corvallis, OR, USA, BS, Physics|
|2009-2012||Research Fellowship, Memorial Sloan Kettering Cancer Center, New York, NY|
|2014||American Board of Radiology|
- Rosenkrantz AB, Koesters T, Vahle AK, Friedman K, Bartlett RM, Taneja SS, Ding YS, Logan J. Quantitative graphical analysis of simultaneous dynamic PET/MRI for assessment of prostate cancer. Clin Nucl Med 40(4):e236-40, 2015. PMID: 25608166.
- Bartlett RM, Beattie BJ, Naryanan M, Georgi JC, Chen Q, Carlin SD, Roble G, Zanzonico PB, Gonen M, O'Donoghue J, Fischer A, Humm JL. Image-guided PO2 probe measurements correlated with parametric images derived from 18F-fluoromisonidazole small-animal PET data in rats. J Nucl Med 53(10):1608-15, 2012. e-Pub 2012. PMID: 22933821.
- Thorek DL, Abou DS, Beattie BJ, Bartlett RM, Huang R, Zanzonico PB, Grimm J. Positron lymphography: multimodal, high-resolution, dynamic mapping and resection of lymph nodes after intradermal injection of 18F-FDG. J Nucl Med 53(9):1438-45, 2012. e-Pub 2012. PMID: 22872741.
- Bartlett RM, Murali D, Nickles RJ, Barnhart TE, Holden JE, DeJesus OT. Assessment of fetal brain uptake of paraquat in utero using in vivo PET/CT imaging. Toxicol Sci 122(2):551-6, 2011. e-Pub 2011. PMID: 21546347.
- Bartlett RM, Dejesus OT, Barnhart TE, Nickles RJ, Christian BT, Graner JL, Holden JE. Fetal dopamine receptor characteristics assessed in utero. J Cereb Blood Flow Metab 30(8):1437-40, 2010. e-Pub 2010. PMID: 20531464.
- Bartlett RM, Nickles RJ, Barnhart TE, Christian BT, Holden JE, DeJesus OT. Fetal dose estimates for (18)F-fluoro-L-thymidine using a pregnant monkey model. J Nucl Med 51(2):288-92, 2010. e-Pub 2010. PMID: 20080884.
- Bartlett RM, Holden JE, Nickles RJ, Murali D, Barbee DL, Barnhart TE, Christian BT, DeJesus OT. Paraquat is excluded by the blood brain barrier in rhesus macaque: An in vivo pet study. Brain Res 1259:74-9, 2009. e-Pub 2008. PMID: 19135428.
- DeJesus OT, Flores LG, Murali D, Converse AK, Bartlett RM, Barnhart TE, Oakes TR, Nickles RJ. Aromatic L-amino acid decarboxylase turnover in vivo in rhesus macaque striatum: a microPET study. Brain Res 1054(1):55-60, 2005. PMID: 16055094.
- DeJesus OT, Flores LG, Roberts AD, Dick DW, Bartlett RM, Murali D, Nickles RJ. Aromatic L-amino acid decarboxylase (AAAD) activity in rhesus macaque striatum after MAO-B inhibition by Ro 16-6491. Synapse 56(1):54-6, 2005. PMID: 15700282.
Books (edited and written)
- Bartlett R, Bolch W, Brill A, Dewaraja Y, Fahey F, Fisher D, Hobbs R, Howell R, Meredith R, Rajendran J, Sgouros G, Zanzonico P. MIRD PRIMER 2020: A Complete Guide to Radiopharmaceutical Dosimetry, 2021.